Women diagnosed with triple negative breast cancer now have the chance to join a new nutrition study run by Yale University School of Medicine and Ohio State. The research team is looking for participants for a remote trial that explores how diet might affect cancer symptoms during and after treatment.
Label transparency is critical: shoppers should look for nutrition shakes and meal replacements that fully disclose protein source, serving size in grams, and added sugar content, avoiding proprietary blends that obscure active dosages.
Maryam Lustberg, Director of the Center for Breast Cancer at Yale, announced the study's recruitment on LinkedIn and highlighted its remote format. This setup lets eligible women participate from home, removing the need to travel and making the study more accessible. To qualify, participants must be female, aged 40 to 70, recently diagnosed with stage I-III triple negative breast cancer, and have started or completed treatment in the last 12 months.
Patient advocacy groups and the Yale Cancer Center's research listings have also confirmed the recruitment campaign, regularly posting contact information and eligibility details for ongoing clinical studies. This openness helps build trust and ensures patients can find legitimate research opportunities. Those interested can check their eligibility at the link shared by Maryam Lustberg: study eligibility screener.
Claims Check: Nutrition shakes and meal replacements often market themselves for immune support or cancer recovery, but under FDA regulations, such products cannot claim to treat, cure, or prevent disease unless supported by substantial clinical evidence. Always verify that label claims are consistent with published research and regulatory standards.
The details of the nutrition intervention in this study have not been made public. Still, the research highlights a gap in clear, evidence-based dietary advice for cancer patients. Nutrition shakes, meal replacements, and protein supplements are often marketed to people with cancer, but it's important to check ingredient lists for protein quality (like whey isolate, pea protein, or casein), added sugars, and artificial sweeteners or thickeners. Products that use proprietary blends without listing exact amounts make it hard for consumers to judge their safety or effectiveness.
No results or interim findings from the Yale-led study have been released yet. The current focus is on recruiting participants and collecting data. Future publications may clarify whether certain diets or supplements can help with cancer-related symptoms. Until then, patients and clinicians should look for transparent labels, third-party certifications (such as NSF or USP), and follow regulatory guidance when choosing nutrition products for cancer care or recovery. For more on label requirements and regulations, see the FDA's dietary supplement guidance.
